Alnylam begins Phase III trial of lumasiran in PH1
PH1 is an ultra-rare disease characterised by excessive oxalate production and renal damage. Credit: John Campbell.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
Kognitic
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust,...
About
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust, insight-driven platform for life sciences, which accelerates our clients' drug development pipeline and investment decisions.
FollowMake an Enquiry
-
Cellular Technology Limited
Cellular Technology Limited (CTL) is a global biotechnology company specialized...
About
Cellular Technology Limited (CTL) is a global biotechnology company specialized in the development, use, and manufacture of standardized tools for cellular immune assays.
FollowMake an Enquiry
-
SWIL Systems
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video...
About
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video conference solutions for clinical researchers, including contract research organisations (CROs), sponsors and institutions.
FollowMake an Enquiry